Our clinical trials with CABA-201 (investigational CD19-CAR T cell therapy) in lupus and myositis are now recruiting.

Our Collaborators

Scientific Collaborators

University of Pennsylvania
Children's Hospital of Philadelphia
UCDavis
Yale

Clinical Collaborators

University of Pennsylvania
UCDavis
Stanford Medicine
The University of Iowa

Industry Partners

Artisanbio
B-MoGen
WuXi AppTec
OxfordBioMedica

Advocacy Partners

LFA
LADA
ippf
MGFA
Cure JM
Nord

Our Cast of Collaborators

Academic and corporate partnerships help accelerate our product development, advance our preclinical studies and clinical trial, and expand the reach of our platform. Collaborations with patient advocacy groups enable us to connect with the patient communities and ensure their voices are heard through our product development journey.